Citation: Gm. Chertow et al., RENAL VASCULITIS WITH HIV SEROPOSITIVITY - POTENTIAL MANIFESTATION OFCYTOMEGALOVIRUS-INFECTION, American journal of kidney diseases, 30(3), 1997, pp. 428-432
Authors:
CHERTOW GM
BURKE SK
LAZARUS JM
STENZEL KH
WOMBOLT D
GOLDBERG D
BONVENTRE JV
SLATOPOLSKY E
Citation: Gm. Chertow et al., POLY[ALLYLAMINE HYDROCHLORIDE] (RENAGEL) - A NONCALCEMIC PHOSPHATE BINDER FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC-RENAL-FAILURE, American journal of kidney diseases, 29(1), 1997, pp. 66-71
Citation: Gm. Chertow, VASCULAR ACCESS IN PATIENTS RECEIVING HEMODIALYSIS - REPLY, JAMA, the journal of the American Medical Association, 277(6), 1997, pp. 456-457
Authors:
CHERTOW GM
BRENNER BM
MORI M
MACKENZIE HS
MILFORD EL
Citation: Gm. Chertow et al., ANTIGEN-INDEPENDENT DETERMINANTS OF GRAFT-SURVIVAL IN LIVING-RELATED KIDNEY-TRANSPLANTATION, Kidney international, 1997, pp. 84-86
Authors:
CHERTOW GM
LAZARUS JM
LEW NL
MA L
LOWRIE EG
Citation: Gm. Chertow et al., DEVELOPMENT OF A POPULATION-SPECIFIC REGRESSION EQUATION TO ESTIMATE TOTAL-BODY WATER IN HEMODIALYSIS-PATIENTS (VOL 51, PG 1578, 1997), Kidney international, 52(1), 1997, pp. 286-286
Authors:
HOU FF
CHERTOW GM
KAY J
BOYCE J
LAZARUS JM
BRAATZ JA
OWEN WF
Citation: Ff. Hou et al., INTERACTION BETWEEN BETA-2-MICROGLOBULIN AND ADVANCED GLYCATION END-PRODUCTS IN THE DEVELOPMENT OF DIALYSIS-RELATED AMYLOIDOSIS, Kidney international, 51(5), 1997, pp. 1514-1519
Authors:
CHERTOW GM
LAZARUS JM
LEW NL
MA LH
LOWRIE EG
Citation: Gm. Chertow et al., DEVELOPMENT OF A POPULATION-SPECIFIC REGRESSION EQUATION TO ESTIMATE TOTAL-BODY WATER IN HEMODIALYSIS-PATIENTS, Kidney international, 51(5), 1997, pp. 1578-1582
Citation: Gm. Chertow et al., BIOELECTRICAL-IMPEDANCE ANALYSIS PREDICTS SURVIVAL IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 969-969
Citation: Ff. Hou et al., BINDING OF BETA-2-MICROGLOBULIN TO COLLAGEN MODIFIED WITH ADVANCED GLYCATION END-PRODUCTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1164-1164
Citation: Ff. Hou et al., AMINOGUANIDINE INHIBITS NONENZYMATIC GLYCOSYLATION OF BETA-2-MICROGLOBULIN, A POTENTIAL THERAPEUTIC ROLE FOR DIALYSIS-RELATED AND AMYLOIDOSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1165-1165
Citation: Gm. Chertow et al., DEVELOPMENT OF A POPULATION-SPECIFIC REGRESSION EQUATION TO ESTIMATE TOTAL-BODY WATER IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1301-1301
Authors:
CHERTOW GM
TRIMBUR T
KARLSON EW
LAZARUS JM
KAY J
Citation: Gm. Chertow et al., PERFORMANCE-CHARACTERISTICS OF A DIALYSIS-RELATED AMYLOIDOSIS QUESTIONNAIRE, Journal of the American Society of Nephrology, 7(8), 1996, pp. 1235-1240
Citation: Jc. Lo et al., FANCONIS-SYNDROME AND TUBULOINTERSTITIAL NEPHRITIS IN ASSOCIATION WITH L-LYSINE INGESTION, American journal of kidney diseases, 28(4), 1996, pp. 614-617
Authors:
CHERTOW GM
MILFORD EL
MACKENZIE HS
BRENNER BM
Citation: Gm. Chertow et al., ANTIGEN-INDEPENDENT DETERMINANTS OF CADAVERIC KIDNEY-TRANSPLANT FAILURE, JAMA, the journal of the American Medical Association, 276(21), 1996, pp. 1732-1736
Citation: Gm. Chertow, GRAFTS VS FISTULAS FOR HEMODIALYSIS-PATIENTS - EQUAL ACCESS FOR ALL, JAMA, the journal of the American Medical Association, 276(16), 1996, pp. 1343-1344
Citation: Md. Denton et al., RENAL-DOSE DOPAMINE FOR THE TREATMENT OF ACUTE-RENAL-FAILURE - SCIENTIFIC RATIONALE, EXPERIMENTAL STUDIES AND CLINICAL-TRIALS, Kidney international, 50(1), 1996, pp. 4-14